 CAMBRIDGE, Mass. , Oct. 17, 2022 PRNewswire -- Nuvalent, Inc. Nasdaq: NUVL, a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that management will host a live webcast and conference call in conjunction with its data presentations at the 34th EORTC-NCI-AACR ENA Symposium in Barcelona, Spain on Friday, October 28, 2022 at 8:30 a.m. 